ARK Investment Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.9M Sell
36,273,288
-990,940
-3% -$1.77M 0.37% 52
2025
Q4
$69.7M Buy
37,264,228
+6,340,125
+21% +$12.2M 0.46% 49
2025
Q3
$39.6M Sell
30,924,103
-5,374,060
-15% -$7.28M 0.24% 62
2025
Q2
$45M Sell
36,298,163
-180,278
-0.5% -$208K 0.33% 50
2025
Q1
$43M Buy
36,478,441
+434,079
+1% +$666K 0.43% 43
2024
Q4
$66M Buy
36,044,362
+2,637,961
+8% +$5.15M 0.55% 35
2024
Q3
$56.8M Buy
33,406,401
+193,947
+0.6% +$319K 0.52% 36
2024
Q2
$45.5M Sell
33,212,454
-77,683
-0.2% -$157K 0.4% 41
2024
Q1
$125M Sell
33,290,137
-1,214,136
-4% -$7.11M 0.86% 31
2023
Q4
$338M Buy
34,504,273
+4,681,833
+16% +$38.3M 2% 17
2023
Q3
$249M Buy
29,822,440
+3,187,820
+12% +$36.4M 1.91% 18
2023
Q2
$354M Sell
26,634,620
-1,119,059
-4% -$13.6M 2.35% 16
2023
Q1
$321M Buy
27,753,679
+2,061,998
+8% +$20.5M 2.21% 17
2022
Q4
$210M Sell
25,691,681
-3,000,813
-10% -$25.9M 1.82% 20
2022
Q3
$167M Buy
28,692,494
+646,964
+2% +$3.71M 1.16% 23
2022
Q2
$158M Buy
28,045,530
+786,009
+3% +$4.78M 0.94% 27
2022
Q1
$248M Buy
27,259,521
+876,418
+3% +$10.1M 1.04% 26
2021
Q4
$540M Buy
26,383,103
+3,660,028
+16% +$88.3M 1.63% 20
2021
Q3
$581M Buy
22,723,075
+2,241,589
+11% +$66.4M 1.39% 22
2021
Q2
$716M Sell
20,481,486
-819,705
-4% -$23.8M 1.33% 23
2021
Q1
$710M Sell
21,301,191
-7,203,438
-25% -$252M 1.41% 17
2020
Q4
$739M Buy
28,504,629
+8,659,849
+44% +$147M 1.97% 11
2020
Q3
$196M Buy
19,844,780
+11,613,288
+141% +$66.9M 1.16% 28
2020
Q2
$28.4M Buy
8,231,492
+4,038,433
+96% +$13.7M 0.31% 51
2020
Q1
$12.8M Buy
4,193,059
+2,683,645
+178% +$11M 0.32% 51
2019
Q4
$7.76M Buy
1,509,414
+752,617
+99% +$3.83M 0.2% 65
2019
Q3
$3.9M Buy
+756,797
New +$4.23M 0.09% 82
2019
Q2
Hold
0
211
2019
Q1
Sell
-590
Closed -$4K 198
2018
Q4
$4K Sell
590
-7,785,895
-100% -$49.3M ﹤0.01% 194
2018
Q3
$42.1M Buy
7,786,485
+1,465,192
+23% +$6.29M 1.27% 30
2018
Q2
$22.4M Buy
6,321,293
+2,036,596
+48% +$5.65M 0.82% 37
2018
Q1
$8.78M Buy
4,284,697
+4,070,780
+1,903% +$10.6M 0.44% 53
2017
Q4
$565K Buy
213,917
+179,192
+516% +$627K 0.05% 114
2017
Q3
$182K Buy
+34,725
New +$149K 0.02% 121

Other funds holding PACB